Related Experiment Video
Updated: Feb 9, 2026

Author Spotlight: An Optimized Automated Method for Investigating Retinoic Acid Receptors in Neuronal Mitochondria
Published on: July 28, 2023
Retinoic Acid Receptor-Related Orphan Receptors: Critical Roles in Tumorigenesis
Jinshuo Fan1, Zhilei Lv1, Guanghai Yang2
1Key Laboratory of Respiratory Diseases of the Ministry of Health, Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Abstract:
Retinoic acid receptor-related orphan receptors (RORs) include RORα (NR1F1), RORβ (NR1F2), and RORγ (NR1F3). These receptors are reported to activate transcription through ligand-dependent interactions with co-regulators and are involved in the development of secondary lymphoid tissues, autoimmune diseases, inflammatory diseases, the circadian rhythm, and metabolism homeostasis. Researches on RORs contributing to cancer-related processes have been growing, and they provide evidence that RORs are likely to be considered as potential therapeutic targets in many cancers. RORα has been identified as a potential therapeutic target for breast cancer and has been investigated in melanoma, colorectal colon cancer, and gastric cancer. RORβ is mainly expressed in the central nervous system, but it has also been studied in pharyngeal cancer, uterine leiomyosarcoma, and colorectal cancer, in addition to neuroblastoma, and recent studies suggest that RORγ is involved in various cancers, including lymphoma, melanoma, and lung cancer. Some studies found RORγ to be upregulated in cancer tissues compared with normal tissues, while others indicated the opposite results. With respect to the mechanisms of RORs in cancer, previous studies on the regulatory mechanisms of RORs in cancer were mostly focused on immune cells and cytokines, but lately there have been investigations concentrating on RORs themselves. Thus, this review summarizes reports on the regulation of RORs in cancer and highlights potential therapeutic targets in cancer.
Insights
Retinoic acid receptor-related orphan receptors (RORs) are emerging as key players in cancer development and progression. This review highlights RORs as potential therapeutic targets for various cancers, including breast, melanoma, and lung cancer.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Retinoic acid receptor-related orphan receptors (RORs), including RORα, RORβ, and RORγ, regulate gene transcription via ligand-dependent co-regulator interactions.
- RORs are implicated in diverse physiological processes such as immune system development, circadian rhythms, and metabolic homeostasis.
- Growing evidence links RORs to various cancer types, positioning them as potential therapeutic targets.
Purpose of the Study:
- To review the current understanding of RORs' roles in cancer.
- To summarize research on the regulatory mechanisms of RORs in cancer.
- To identify potential therapeutic strategies targeting RORs in oncology.
Main Methods:
- Literature review of studies investigating RORs in cancer.
- Analysis of research focusing on ROR regulation and function in neoplastic processes.
- Synthesis of findings related to RORs as therapeutic targets in various malignancies.
Main Results:
- RORα is a potential target in breast cancer, melanoma, colorectal, and gastric cancers.
- RORβ, primarily in the CNS, is studied in pharyngeal cancer, uterine leiomyosarcoma, colorectal cancer, and neuroblastoma.
- RORγ is implicated in lymphoma, melanoma, and lung cancer, with conflicting reports on its expression levels in tumor tissues.
Conclusions:
- RORs play significant roles in cancer, acting as potential therapeutic targets.
- Further research into ROR regulatory mechanisms in cancer is warranted.
- Targeting RORs may offer novel therapeutic avenues for diverse cancer types.
More Related Videos
Related Concept Videos
Internal Receptors
Receptor-mediated Endocytosis
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
G-protein Coupled Receptors
Types of Receptors: Internal Receptors
Similar to membrane-bound receptors, the binding of a ligand to the intracellular receptor of causes a conformational change in the...
Types of Receptors: Cell Surface Receptors

